Z 2985 Z 2985
Pill imprint Z 2985 Z 2985 has been identified as Doxycycline hyclate 100 mg.
Doxycycline is used in the treatment of urinary tract infection; chlamydia infection; acne; rosacea; bacterial infection (and more), and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy.
Doxycycline 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Doxycycline hyclate Images
- Imprint:
-
Z 2985
Z 2985 - Strength:
- 100 mg
- Color:
- Blue
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antimalarials
Tetracyclines - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00172-2985
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00182-1035 | Goldline Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Doxycycline Hyclate resources
- Doxycycline
- Doxycycline (Wolters Kluwer)
- Doxycycline Capsules (Wolters Kluwer)
- Doxycycline Hyclate (Wolters Kluwer)
- Doxycycline Hyclate Delayed-Release Capsules (Wolters Kluwer)
- Doxycycline Hyclate Delayed-Release Tablets (Wolters Kluwer)
- Doxycycline Kit (Wolters Kluwer)
- Doxycycline Monohydrate (Wolters Kluwer)
- Doxycycline Suspension (Wolters Kluwer)
- Doxycycline Syrup (Wolters Kluwer)
- Doxycycline Tablets (Wolters Kluwer)
- Doxycycline with Cleanser (Wolters Kluwer)
- doxycycline (Cerner Multum)
- Adoxa Pak (Micromedex) - Includes Dosage Information
- Atridox (Micromedex) - Includes Dosage Information
- Vibramycin Hyclate (Micromedex) - Includes Dosage Information
- doxycycline (Micromedex) - Includes Dosage Information
- doxycycline Subgingival (Micromedex) - Includes Dosage Information
- Doxycycline (AHFS DI)
- Doxycycline Calcium (AHFS DI)
- Doxycycline Hyclate (AHFS DI)
- Doxycycline Hyclate eent (AHFS DI)
- Doxycycline Monohydrate (AHFS DI)
- Doxycycline (FDA)
- Doxycycline Hyclate (FDA)
- Doxycycline Hyclate Delayed Release (FDA)
- Doxycycline Hyclate Tablets (FDA)
- Doxycycline Injection (FDA)
- Doxycycline Monohydrate (FDA)
- Doxycycline Tablets (FDA)
- Doxycyline Suspension (FDA)
- Doxycycline (Wolters Kluwer)
Doxycycline Hyclate is associated with the treatment of:
- Acne
- Actinomycosis
- Amebiasis
- Anthrax
- Anthrax Prophylaxis
- Bacterial Infection
- Bartonellosis
- Bronchitis
- Brucellosis
- Bullous Pemphigoid
- Chlamydia Infection
- Cholera
- Cutaneous Bacillus anthracis
- Ehrlichiosis
- Enterocolitis
- Epididymitis, Sexually Transmitted
- Gastroenteritis
- Granuloma Inguinale
- Inclusion Conjunctivitis
- Lyme Disease
- Lyme Disease, Arthritis
- Lyme Disease, Carditis
- Lyme Disease, Erythema Chronicum Migrans
- Lyme Disease, Neurologic
- Lymphogranuloma Venereum
- Malaria
- Malaria Prevention
- Melioidosis
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Ocular Rosacea
- Ornithosis
- Pelvic Inflammatory Disease
- Pemphigoid
- Pemphigus
- Periodontitis
- Plague
- Pleural Effusion
- Pneumonia
- Proctitis
- Prostatitis
- Psittacosis
- Rabbit Fever
- Rheumatoid Arthritis
- Rickettsial Infection
- Rosacea
- Skin Infection
- STD Prophylaxis
- Syphilis, Early
- Syphilis, Latent
- Tertiary Syphilis
- Trachoma
- Upper Respiratory Tract Infection
- Urinary Tract Infection
Search Again
